This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2016 Apr 20;34(12):e110-6.

doi: 10.1200/JCO.2013.50.9471. Epub 2014 Oct 27.

Targeting Tumor-Infiltrating B Cells in Cutaneous T-Cell Lymphoma

Affiliations

Affiliations

¹ University Hospital of Cologne, Cologne, Germany sebastian.theurich@uk-koeln.de.
² University Hospital of Cologne, Cologne, Germany.
³ Johannes-Wessling-Hospital, Minden, Germany.

PMID: 25348001
DOI: 10.1200/JCO.2013.50.9471

Case Reports

Targeting Tumor-Infiltrating B Cells in Cutaneous T-Cell Lymphoma

Sebastian Theurich et al. J Clin Oncol. 2016.

. 2016 Apr 20;34(12):e110-6.

doi: 10.1200/JCO.2013.50.9471. Epub 2014 Oct 27.

Affiliations

¹ University Hospital of Cologne, Cologne, Germany sebastian.theurich@uk-koeln.de.
² University Hospital of Cologne, Cologne, Germany.
³ Johannes-Wessling-Hospital, Minden, Germany.

PMID: 25348001
DOI: 10.1200/JCO.2013.50.9471

No abstract available

PubMed Disclaimer

Similar articles

Primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoma: temporary remission by oral doxycycline.
Toberer F, Hartschuh W, Hadaschik E. Toberer F, et al. JAMA Dermatol. 2013 Aug;149(8):956-9. doi: 10.1001/jamadermatol.2013.4162. JAMA Dermatol. 2013. PMID: 23760549
Primary Cutaneous Gamma-Delta T-cell Lymphoma: Not an Aggressive Disease in All Cases.
Khallaayoune M, Grange F, Condamina M, Szablewski V, Guillot B, Dereure O. Khallaayoune M, et al. Acta Derm Venereol. 2020 Jan 23;100(1):adv00035. doi: 10.2340/00015555-3340. Acta Derm Venereol. 2020. PMID: 31612963 Free PMC article. No abstract available.
Multispectral Imaging Approach to the Diagnosis of a CD20+ Cutaneous T-cell Lymphoproliferative Disorder: A Case Report.
Salva KA, Bennett D, Longley J, Guitart J, Wood GS. Salva KA, et al. Am J Dermatopathol. 2015 Oct;37(10):e116-21. doi: 10.1097/DAD.0000000000000323. Am J Dermatopathol. 2015. PMID: 26381030 Free PMC article.
Systemic eight-cycle anti-CD20 monoclonal antibody (rituximab) therapy in primary cutaneous B-cell lymphomas--an applicational observation.
Gellrich S, Muche JM, Wilks A, Jasch KC, Voit C, Fischer T, Audring H, Sterry W. Gellrich S, et al. Br J Dermatol. 2005 Jul;153(1):167-73. doi: 10.1111/j.1365-2133.2005.06659.x. Br J Dermatol. 2005. PMID: 16029344 Review.
[THE MECHANISMS OF ACTION OF RITUXIMAB].
Gil'deeva GN, Kudlai DA, Luk'yanov SV. Gil'deeva GN, et al. Eksp Klin Farmakol. 2015;78(12):51-6. Eksp Klin Farmakol. 2015. PMID: 27051930 Review. Russian.

See all similar articles

Cited by

B cells and the humoral response in melanoma: The overlooked players of the tumor microenvironment.
Chiaruttini G, Mele S, Opzoomer J, Crescioli S, Ilieva KM, Lacy KE, Karagiannis SN. Chiaruttini G, et al. Oncoimmunology. 2017 Mar 3;6(4):e1294296. doi: 10.1080/2162402X.2017.1294296. eCollection 2017. Oncoimmunology. 2017. PMID: 28507802 Free PMC article. Review.
Immune cells in the B-cell lymphoma microenvironment: From basic research to clinical applications.
Zhang W, Liu M, Li W, Song Y. Zhang W, et al. Chin Med J (Engl). 2024 Apr 5;137(7):776-790. doi: 10.1097/CM9.0000000000002919. Epub 2024 Jan 25. Chin Med J (Engl). 2024. PMID: 38269619 Free PMC article. Review.
Cutaneous T cell lymphoma atlas reveals malignant T_H2 cells supported by a B cell-rich tumor microenvironment.
Li R, Strobl J, Poyner EFM, Balbaa A, Torabi F, Mazin PV, Chipampe NJ, Stephenson E, Ramírez-Suástegi C, Shanmugiah VBM, Gardner L, Olabi B, Coulthard R, Botting RA, Zila N, Prigmore E, Gopee NH, Chroscik MA, Kritikaki E, Engelbert J, Goh I, Chan HM, Johnson HF, Ellis J, Rowe V, Tun W, Reynolds G, Yang D, Foster AR, Gambardella L, Winheim E, Admane C, Rumney B, Steele L, Jardine L, Nenonen J, Pickard K, Lumley J, Hampton P, Hu S, Liu F, Liu X, Horsfall D, Basurto-Lozada D, Grimble L, Bacon CM, Weatherhead SC, Brauner H, Wang Y, Bai F, Reynolds NJ, Allen JE, Jonak C, Brunner PM, Teichmann SA, Haniffa M. Li R, et al. Nat Immunol. 2024 Dec;25(12):2320-2330. doi: 10.1038/s41590-024-02018-1. Epub 2024 Nov 18. Nat Immunol. 2024. PMID: 39558094 Free PMC article.
Enhancing antitumor immunity through checkpoint blockade as a therapeutic strategy in T-cell lymphomas.
Neuwelt A, Al-Juhaishi T, Davila E, Haverkos B. Neuwelt A, et al. Blood Adv. 2020 Sep 8;4(17):4256-4266. doi: 10.1182/bloodadvances.2020001966. Blood Adv. 2020. PMID: 32898250 Free PMC article. Review.
Human Colorectal Carcinoma Infiltrating B Lymphocytes Are Active Secretors of the Immunoglobulin Isotypes A, G, and M.
Mullins CS, Gock M, Krohn M, Linnebacher M. Mullins CS, et al. Cancers (Basel). 2019 Jun 4;11(6):776. doi: 10.3390/cancers11060776. Cancers (Basel). 2019. PMID: 31167511 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- MedlinePlus Health Information